AdvanCell

AdvanCell

AdvanCell develops targeted radiopharmaceuticals for the diagnosis and treatment of cancer.

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $112M

About

AdvanCell develops targeted radiopharmaceuticals for the diagnosis and treatment of cancer.

OncologyDiagnostics

Funding History

1
Total raised:$112M
Series B$112M